Covid-19: Early vaccine results show no major safety issue

The US government has awarded Novavax, a company based in Gaithersburg, Maryland, $1.6 billion to help develop and make the vaccine, which is given as two shots, three weeks apart. It includes a protein from the coronavirus to prompt the immune system to make antibodies to fight infection.The US government has awarded Novavax, a company based in Gaithersburg, Maryland, $1.6 billion to help develop and make the vaccine, which is given as two shots, three weeks apart. It includes a protein from the coronavirus to prompt the immune system to make antibodies to fight infection.

Leave a Reply

Your email address will not be published. Required fields are marked *